Q9972 Epoetin Beta Injection Reimbursement | OpenPayer

Summary & Overview

HCPCS Q9972: Epoetin Beta Injection, 1 microgram (ESRD on Dialysis)

HCPCS Level II code Q9972 denotes a 1-microgram unit of epoetin beta administered for patients with end-stage renal disease (ESRD) who are undergoing dialysis. As an erythropoiesis-stimulating agent (ESA), epoetin beta is used to manage anemia associated with chronic kidney disease and dialysis; capturing unit-based dosing with a specific HCPCS Level II code supports accurate billing, inventory tracking, and payment reconciliation across outpatient dialysis settings. Nationally, ESAs remain a high-cost drug category with significant implications for dialysis treatment protocols, payer coverage policies, and facility reimbursement.

Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find concise guidance on the clinical context of Q9972, typical sites of service where it is billed, and what to expect when this code appears on dialysis-related service lines. The publication outlines common benchmarking and billing considerations, summarizes payer coverage scope at a national level, and highlights policy-relevant issues such as unit-based drug reporting and implications for dialysis facility cost management. Data not available in the input is noted where specific payer policies, modifiers, taxonomies, ICD-10 pairings, and related codes would normally be listed.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareQ9972HCPCS Level IIepoetin betaESRDdialysiserythropoiesis-stimulating agentinjectionoutpatient dialysis

Billing Code Overview

HCPCS Level II code Q9972 represents Injection, epoetin beta, 1 microgram, (for ESRD on dialysis). This code indicates a billed unit of the erythropoiesis-stimulating agent epoetin beta specifically measured per 1 microgram dose in the context of patients with end-stage renal disease (ESRD) receiving dialysis.

Service type: Therapeutic injection (erythropoiesis-stimulating agent)

Typical site of service: Dialysis clinic or hospital outpatient dialysis unit

Clinical & Coding Specifications

Clinical Context

A typical patient is an adult with end-stage renal disease (ESRD) receiving maintenance hemodialysis three times per week at an outpatient dialysis center. The patient has laboratory-confirmed anemia related to chronic kidney disease, with hemoglobin levels consistently below facility targets despite oral iron therapy and prior erythropoiesis-stimulating agent (ESA) management. The dialysis nursing staff prepares and administers Q9972 (injection, epoetin beta, 1 microgram) via subcutaneous or intravenous route during or immediately after a dialysis session per the facility’s medication administration protocol. The workflow includes physician order review, verification of dose and route, documentation of pre- and post-administration vital signs, and recording dose and lot number in the dialysis treatment record. Billing staff submit Q9972 on the claim for the medication administered during the dialysis encounter, with appropriate diagnosis codes supporting ESRD and anemia.

Coding Specifications

Modifier	Description	When to Use
`JW`	Drug amount discarded/not administered	Use when part of a single-use vial is discarded and payer requires reporting of discarded portion for injectable biologics.

HCPCS Q4304: Grafix Plus, Biologic Graft per Square Centimeter

HCPCS-Q4425-REVIVE-TL-PER-SQUARE-CENTIMETER

HCPCS Q4425: Revive tl, Per Square Centimeter (Add-on)

HCPCS-Q2041-AXICABTAGENE-CILOLEUCEL-CAR-T-CELL-THERAPY

HCPCS Q2041: Axicabtagene ciloleucel CAR T-cell Therapy

HCPCS-Q5102-INFLIXIMAB-BIOSIMILAR-10MG-INJECTION

HCPCS Level II Q5102: Infliximab Biosimilar Injection, 10 mg

HCPCS-Q5007-HOSPICE-CARE-LONG-TERM-CARE-FACILITY

HCPCS Q5007: Hospice Care in Long Term Care Facility

HCPCS-Q4189-ARTACENT-AC-1MG-INJECTABLE

HCPCS Q4189: Artacent ac, 1 mg

HCPCS-Q4259-CELERA-DUAL-MEMBRANE-PER-CM2

HCPCS Level II Q4259: Celera Dual Membrane, Per Square Centimeter

HCPCS-Q4142-XCM-BIOLOGIC-TISSUE-MATRIX-ADD-ON

HCPCS Q4142: Xcm Biologic Tissue Matrix, Per cm² (Add-On)

HCPCS-Q4377-TRIGRAFT-PER-SQUARE-CENTIMETER-GRAFT

HCPCS Q4377: Trigraft per Square Centimeter, Add-on Graft Supply

HCPCS-Q4296-REBOUND-MATRIX-PER-SQ-CM

HCPCS Q4296: Rebound Matrix, Per Square Centimeter

Showing 1–10 of 629

Taxonomy Code	Specialty	Notes
`2080P0207X`	Nephrology	Primary specialty managing ESRD and prescribing ESAs in dialysis patients.
`282N00000X`	Registered Nurse	Nurses administer `Q9972` in dialysis centers and document medication administration.
`367A00000X`	Dialysis Facility/Facility-based Provider	Facility taxonomy representing outpatient dialysis centers where ESAs are commonly administered.
`207L00000X`	Internal Medicine	Hospitalists/internists who co-manage anemia in CKD/ESRD patients may prescribe ESAs.
`208000000X`	Hematology	Hematologists consult on complex anemia management and ESA dosing in dialysis-dependent anemia.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`N18.6`	End stage renal disease	Primary indication for dialysis-dependent anemia management and ESA therapy with `Q9972`.
`D63.1`	Anemia in chronic kidney disease	Direct diagnosis supporting medical necessity for erythropoiesis-stimulating agents such as epoetin beta.
`N18.5`	Chronic kidney disease, stage 5	Indicates severe CKD that often progresses to ESRD and may warrant ESA use prior to or during dialysis.
`Z99.2`	Dependence on renal dialysis	Administrative/encounter diagnosis that documents dialysis dependence associated with ESA administration.
`D50.9`	Iron deficiency anemia, unspecified	Common comorbidity; iron status assessment influences ESA dosing and effectiveness.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`96372`	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular	Commonly used to report ancillary professional administration of an injection when facility billing does not include administration; may be used if separate administration service is billed alongside `Q9972`.
`99199`	Unlisted special service, procedure or report	Occasionally used for facility-specific or manufacturer-specific administration or monitoring services not described by standard CPT codes (payer-specific).
`36415`	Collection of venous blood by venipuncture	Performed routinely for pre-dose hemoglobin and iron studies to guide ESA dosing.
`96365`	Intravenous infusion, therapeutic, prophylactic, or diagnostic; initial, up to 1 hour	Used when ESA is administered via intravenous infusion rather than injection in unique situations (rare for epoetin beta dosing).
`99070`	Supplies and materials (except spectacles), non-physician providers	Used to report additional supplies associated with administration (needles, syringes) in some billing contexts.

OpenPayer